期刊文献+

冠心病患者心率变异与氨基末端脑钠肽前体的相关性研究 被引量:5

Study on the Correlation between Heart Rate Variability and N-Terminal Pro-Brain Natriuretic Peptide Value in Coronary Heart Disease
下载PDF
导出
摘要 目的探讨冠心病患者的心率变异性(heart rate variability,HRV)与氨基末端脑钠肽前体(N-Terminal pro-Brain Natriuretic Peptide,NT-proBNP)的相关性。方法选取71例非冠心病患者及52例冠心病患者,完成动态心电图,选时域指标中SDANN代表HRV,采用电化学发光法测量NT-proBNP,分析HRV与NT-proBNP的相关性;结果冠心病组与非冠心病组相比,其HRV降低[(93.27±25.05)ms比(103.00±24.15)ms],而NTproBNP升高[(283.56±518.76)pg/m L比(60.07±104.31)pg/m L],其差异有极显著性意义(P<0.01);并且HRV与NT-proBNP呈负相关(r=-0.202,t=-2.015,P=0.047)。结论冠心病患者HRV及NT-proBNP发生改变,同时HRV是NT-proBNP水平的独立影响因素。 Objective To study the changes of heart rate variability (HRV) and N - Terminal Pro - Brain Natriuret- ic Peptide (NT -proBNP) and illustrate the correlation between heart rate variability (HRV) and NT- proBNP in coronary heart disease (CHD). Methods Two groups of participants were studied in this study: 71 patients without CHDpatients and 52 patients with CHD. The time domain parameters of 24 hours HRV were detected by 24 hour electrocardiographic monito- ring; NT- proBNP was measured by electrochemiluminescence in these patients. Results The HRV value ~ (93.27 _+ 25.05 ) ms vs ( 103.00 + 24. 15 ) ms ] was lower and the NT - proBNP value [ ( 283.56 + 518.76 ) pg/mL vs ( 60. 07 -+ 104. 31 ) pg/mL] was higher in Group A than those in Group B (P 〈0. 01 ) , and HRV value was negatively correlation with NT - proBNP( r = - 0. 202, t = - 2. 015,P = 0. 047 ). Conclusion The HRV value and the NT - proBNP value in CHD pa- tients changed, which suggest that lower HRV is a potential risky factor that may affect the NT - proBNP value in patients with CHD.
机构地区 粤北人民医院
出处 《现代医院》 2017年第2期227-229,共3页 Modern Hospitals
基金 韶关市医药卫生科研计划项目(编号:Y15019) 韶关市科技局计划项目(编号:2015CX/K028)
关键词 冠心病 心率变异 氨基末端脑钠肽前体 Coronary Heart Disease Heart Rate Variability N -Terminal pro- Brain Natriuretic Peptide
  • 相关文献

参考文献4

二级参考文献43

  • 1LEE J H,PARK H S,CHAE S C,et al.Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry)[J].Am J Cardiol,2009,104(2):182-189.
  • 2KWON T G,BAE J H,JEONG M H,et al.N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention[J].Int J Cardiol,2009,133(2):173-178.
  • 3SUDOH T,KANGAWA K,MINAMINO N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332:78-81.
  • 4RICHARDS A M,NICHOLLS M G,YANDLE T G,et al.Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin:new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction[J].Circulation,1998,97(19):1921-1929.
  • 5KUKLINSKA A M,SOBKOWICZ B,KAMINSKI K A,el al.The Benefits of Repeated Measurements of B-type atriuretic Peptide in Patients With First ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention[J].Int Heart J,2006,47:843-854.
  • 6HAECK J D,VEROUDEN N J,KUIJT W J,et al.Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Am J Cardiol,2010,105(8):1065-1069.
  • 7Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2014)[EB/OL]. http://www.goldcopd.org/ Global Initiative for Chronic Obstructive Lung Disease.
  • 8Kilbride HS, Stevens PE, Eaglestone G, et al. Accuracy of the MDRD (modification of diet in renal disease)study and CKD-EPI (CKD epidemiology collaboration) equations for estimation of GFR in the elderly [J]. Am J Kidney Dis, 2013, 61(1):57-66.
  • 9McMurray J J, Adamopoulos S, Anker SD, et ",d. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaborationwith the Heart Failure Association (HFA) of the ESC [J]. Eur J Heart Fail, 2012, 14 ( 8 ) : 803-869.
  • 10Hannink JDC, Van Helvoort HAC, Dekhuijzen PNR, et al. Heart failure and COPD: partners in crime? [J]. Respirology, 2010, 15(6): 895-901.

共引文献58

同被引文献70

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部